Vanda Pharmaceuticals Receives Revised Unsolicited Acquisition Proposal From Future Pak For $8.50-$9.00 Per Share In Cash Plus Contingent Value Rights; No Shareholder Action Required At This Time
Vanda Pharmaceuticals Receives Revised Unsolicited Acquisition Proposal From Future Pak For $8.50-$9.00 Per Share In Cash Plus Contingent Value Rights; No Shareholder Action Required At This Time
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.